This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fischer, S. M. Articles by Bechtel, D. H. Search for Related Content PubMed PubMed Citation Articles by Fischer, S. M. Articles by Bechtel, D. H.

The Effect of Dietary Fat on the Rapid Development of Mammary Tumors Induced by 7,12-Dimethylbenz(a)anthracene in SENCAR Mice¹

The University of Texas M. D. Anderson Cancer Center, Science Park Research Division, Smithville, Texas 78957 [S. M. F., C. J. C., R. E. M., M. L. L., J. L., T. J. S.]; The University of Texas at Austin, Division of Nutrition, Austin, Texas 78712 [M. A. B., M. L.]; and Best Foods, Inc., Research and Engineering, Union, New Jersey 07083 [D. B.]

We recently reported (J. Leyton et al., Cancer Res., 51: 907–915, 1991) an inverse correlation between skin tumor number and level of dietary linoleic acid (LA) in SENCAR mice following an initiationpromotion protocol. These results differed from the reported (C. Ip et al., Cancer Res., 45: 1997–2001, 1985) positive correlation between dietary LA and tumor incidence for the rat mammary gland. The goal of the study reported here was to determine whether this dissimilarity was due to organ site or species differences. Female SENCAR mice were fed 1 of 3 15% fat diets containing LA at levels of 0.8, 4.5, and 8.4% before, during, and after intragastric administration of 6 mg (1 mg/week) 7,12-dimethylbenz(a)anthracene. A positive correlation between level of dietary LA and mammary tumor incidence was observed such that for the first 15 weeks, the incidence was greatest in the 8.4% LA diet group, followed by the 4.5% and then the 0.8% LA groups. Distinct dietary effects on latency were also noted in that 15, 12, and 8 weeks after cessation of 7,12-dimethylbenz(a)anthracene were required for a 40% carcinoma incidence in the 0.8, 4.5, and 8.4% LA diet groups, respectively. A histopathological analysis of all tumors revealed that the predominant type was the adenosquamous carcinoma, which comprised 46.6, 54.1, and 77.7% of all mammary tumors for diets containing 0.8, 4.5, and 8.4% LA, respectively. The second most common tumor was the adenocarcinoma type B, which was found with a frequency of 33% in the 0.8% and 4.5% LA diet groups and 22% in the 8.4% LA diet group. These results indicate that SENCAR mice have a short latency period for 7,12-dimethylbenz(a)anthracene-induced mammary tumor development and that rat and mouse mammary tumor development is modified by dietary LA in a similar manner, although in the SENCAR mouse dietary LA did not have a saturating effect. In addition, high dietary LA was found to be associated specifically with an increased incidence of adenosquamous carcinomas but not of other types of mammary tumors.

¹ This work was supported by a grant from Best Foods, Inc., and NIH CORE Grant 16672; M. B. was supported by National Institute of Environmental Health Sciences Grant ES-07247.

² To whom requests for reprints should be addressed at University of Texas Cancer Center, Science Park, P. O. Box 389, Smithville, TX 78957.

Received 9/ 5/91. Accepted 11/13/91.

This article has been cited by other articles:

				T. L. Guo, R. P. Chi, D. M. Hernandez, W. Auttachoat, and J. F. Zheng Decreased 7,12-dimethylbenz[a]anthracene-induced carcinogenesis coincides with the induction of antitumor immunities in adult female B6C3F1 mice pretreated with genistein Carcinogenesis, December 1, 2007; 28(12): 2560 - 2566. [Abstract] [Full Text] [PDF]

				C. J. Nicol, M. Yoon, J. M. Ward, M. Yamashita, K. Fukamachi, J. M. Peters, and F. J. Gonzalez PPAR{gamma} influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis Carcinogenesis, September 1, 2004; 25(9): 1747 - 1755. [Abstract] [Full Text] [PDF]

				S. Banni, E. Angioni, V. Casu, M. P. Melis, G. Carta, F. P. Corongiu, H. Thompson, and C. Ip Decrease in linoleic acid metabolites as a potential mechanism in cancer risk reduction by conjugated linoleic acid Carcinogenesis, June 1, 1999; 20(6): 1019 - 1024. [Abstract] [Full Text] [PDF]

				V. E. Steele, C. A. Holmes, E. T. Hawk, L. Kopelovich, R. A. Lubet, J. A. Crowell, C. C. Sigman, and G. J. Kelloff Lipoxygenase Inhibitors as Potential Cancer Chemopreventives Cancer Epidemiol. Biomarkers Prev., May 1, 1999; 8(5): 467 - 483. [Abstract] [Full Text]